126 related articles for article (PubMed ID: 30323095)
1. Toward a Personalized Approach in the Treatment of Salivary Ductal Carcinoma.
Tsai FD; Haddad RI
J Natl Compr Canc Netw; 2018 Oct; 16(10):1269-1270. PubMed ID: 30323095
[No Abstract] [Full Text] [Related]
2. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
Gargano SM; Senarathne W; Feldman R; Florento E; Stafford P; Swensen J; Vranic S; Gatalica Z
Cancer Med; 2019 Dec; 8(17):7322-7329. PubMed ID: 31609094
[TBL] [Abstract][Full Text] [Related]
3. Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trial.
Weijers JAM; de Bitter TJJ; Verhaegh GW; van Boxtel W; Uijen MJM; van Engen-van Grunsven ACH; Driessen CML; Schalken JA; Ligtenberg MJL; van Herpen CML
Oral Oncol; 2023 Dec; 147():106620. PubMed ID: 37939426
[No Abstract] [Full Text] [Related]
4. Salivary gland tumors: Molecular characterization and therapeutic advances for metastatic disease.
Schvartsman G; Pinto NA; Bell D; Ferrarotto R
Head Neck; 2019 Jan; 41(1):239-247. PubMed ID: 30552848
[TBL] [Abstract][Full Text] [Related]
5. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.
Nardi V; Sadow PM; Juric D; Zhao D; Cosper AK; Bergethon K; Scialabba VL; Batten JM; Borger DR; Iafrate AJ; Heist RS; Lawrence DP; Flaherty KT; Bendell JC; Deschler D; Li Y; Wirth LJ; Dias-Santagata D
Clin Cancer Res; 2013 Jan; 19(2):480-90. PubMed ID: 23186780
[TBL] [Abstract][Full Text] [Related]
6. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.
Mitani Y; Rao PH; Maity SN; Lee YC; Ferrarotto R; Post JC; Licitra L; Lippman SM; Kies MS; Weber RS; Caulin C; Lin SH; El-Naggar AK
Clin Cancer Res; 2014 Dec; 20(24):6570-81. PubMed ID: 25316813
[TBL] [Abstract][Full Text] [Related]
7. Primary salivary duct carcinoma of the lung, mucin-rich variant.
Fishbein GA; Grimes BS; Xian RR; Lee JM; Barjaktarevic I; Xu H
Hum Pathol; 2016 Jan; 47(1):150-6. PubMed ID: 26527521
[TBL] [Abstract][Full Text] [Related]
8. Salivary duct carcinoma: what is already known, and can we improve survival?
Wee DT; Thomas AA; Bradley PJ
J Laryngol Otol; 2012 Jul; 126 Suppl 2():S2-7. PubMed ID: 22495125
[TBL] [Abstract][Full Text] [Related]
9. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.
Yamamoto H; Uryu H; Segawa Y; Tsuneyoshi M
Pathol Int; 2008 May; 58(5):322-6. PubMed ID: 18429833
[TBL] [Abstract][Full Text] [Related]
10. First-Line Treatment of Widely Metastatic
Lin VTG; Nabell LM; Spencer SA; Carroll WR; Harada S; Yang ES
J Natl Compr Canc Netw; 2018 Oct; 16(10):1166-1170. PubMed ID: 30323086
[TBL] [Abstract][Full Text] [Related]
11. Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment.
Nakaguro M; Tada Y; Faquin WC; Sadow PM; Wirth LJ; Nagao T
Cancer Cytopathol; 2020 Oct; 128(10):693-703. PubMed ID: 32421944
[TBL] [Abstract][Full Text] [Related]
12. Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations.
Bishop JA; Nakaguro M; Whaley RD; Ogura K; Imai H; Laklouk I; Faquin WC; Sadow PM; Gagan J; Nagao T
Histopathology; 2021 Sep; 79(3):338-346. PubMed ID: 33135196
[TBL] [Abstract][Full Text] [Related]
13. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
Santana T; Pavel A; Martinek P; Steiner P; Grossmann P; Baněčková M; Skálová A
Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
[TBL] [Abstract][Full Text] [Related]
14. [Salivary duct carcinoma--a clinicopathological analysis of five cases].
Bień S; Sygut J; Kopczyński J; Postuła S; Ziółkowska M
Otolaryngol Pol; 2007; 61(1):33-8. PubMed ID: 17605416
[TBL] [Abstract][Full Text] [Related]
15. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.
Di Palma S; Simpson RH; Marchiò C; Skálová A; Ungari M; Sandison A; Whitaker S; Parry S; Reis-Filho JS
Histopathology; 2012 Oct; 61(4):629-43. PubMed ID: 22882517
[TBL] [Abstract][Full Text] [Related]
16. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.
Saintigny P; Mitani Y; Pytynia KB; Ferrarotto R; Roberts DB; Weber RS; Kies MS; Maity SN; Lin SH; El-Naggar AK
Cancer; 2018 Sep; 124(18):3693-3705. PubMed ID: 30289966
[TBL] [Abstract][Full Text] [Related]
17. Salivary duct carcinoma with neuroendocrine features.
Laforga JB
Virchows Arch; 2004 May; 444(5):473-6. PubMed ID: 15014988
[No Abstract] [Full Text] [Related]
18. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
[TBL] [Abstract][Full Text] [Related]
19. Salivary duct carcinoma.
Thompson LD
Ear Nose Throat J; 2012 Sep; 91(9):356, 359. PubMed ID: 22996706
[No Abstract] [Full Text] [Related]
20. Osteoclast-type giant cell tumor of minor salivary gland with mucin-rich salivary duct carcinoma: a case report of unusual histology with immunohistochemical analysis.
Kusafuka K; Nakamura S; Asano R; Kamijo T; Iida Y; Onistuka T; Nakajima T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):870-7. PubMed ID: 20346712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
